{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:10:20Z","timestamp":1793679020871,"version":"4.5.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D program of China","doi-asserted-by":"crossref","award":["2017YFA0103204"],"award-info":[{"award-number":["2017YFA0103204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010229","name":"Natural Science Foundation of Tianjin Municipal Science and Technology Commission","doi-asserted-by":"crossref","award":["81670830"],"award-info":[{"award-number":["81670830"]}],"id":[{"id":"10.13039\/501100010229","id-type":"DOI","asserted-by":"crossref"}]},{"name":"General Hospital of People\u00e2\u20acs Liberation Army","award":["2016TM-025"],"award-info":[{"award-number":["2016TM-025"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this study was to evaluate the long-term incidence, risk factors, and the management of corneal melt following Boston type I keratoprosthesis (B-KPro I) implantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a retrospective observational case series. Data were collected regarding demographics, preoperative characteristics, incidence, and outcomes of corneal melt in 102 patients who underwent B-KPro I in the Chinese PLA General Hospital between 2011 and 2018, with a follow-up period ranging from 4 to 11 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Chemical burn was the most common indication for B-KPro I (n = 56; 53.8%), followed by ocular trauma (n = 26; 25.0%). During the follow-up period (107 \u00b1 25.7 months), corneal melt occurred in 60 cases among 37 eyes (35.6%), with an incidence of 20.2% at 1 year after surgery. Fourteen cases presented with recurrent corneal melt. Patients with multiple corneal allograft failures had a higher risk of corneal melt. Thermal burns, compared with alkali burns, significantly elevated the odds ratio (OR) of corneal melt (OR, 5.11; 95% confidence interval, 1.05\u201324.86; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.043).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Corneal melt significantly reduced the retention time of KPro (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01), and its coexistence with other complications further shortened the retention time. A specific pattern of corneal melt occurrence was identified, with a peak incidence at 1 year postoperatively. Our findings suggest variations in the risk of corneal melt among different indications, with thermal burns carrying the highest OR. Moreover, each previous failed keratoplasty doubled the risk of corneal melt after B-KPro I.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ico.0000000000003563","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:02:12Z","timestamp":1715083332000},"page":"936-941","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Causes of Corneal Melt After the Boston Keratoprosthesis Type I: The Chinese People's Liberation Army General Hospital Experience"],"prefix":"10.1097","volume":"43","author":[{"given":"Zhe","family":"Yang","sequence":"first","affiliation":[{"name":"Medical School of Chinese PLA, Beijing, China;"},{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"},{"name":"School of Medicine, Nankai University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"},{"name":"School of Medicine, Nankai University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"},{"name":"School of Medicine, Nankai University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"},{"name":"School of Medicine, Nankai University, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"R1-20250723","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-vision-100820-021253","article-title":"The Boston Keratoprosthesis-the first 50 years: some reminiscences","volume":"8","author":"Dohlman","year":"2022","journal-title":"Annu Rev Vis Sci"},{"key":"R2-20250723","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/bjophthalmol-2014-306161","article-title":"The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure","volume":"99","author":"Fadous","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R3-20250723","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ICU.0b013e32833a8da2","article-title":"Management of ocular thermal and chemical injuries, including amniotic membrane therapy","volume":"21","author":"Fish","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"R4-20250723","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s41433-019-0456-5","article-title":"An update on chemical eye burns","volume":"33","author":"Bizrah","year":"2019","journal-title":"Eye (Lond)"},{"key":"R5-20250723","doi-asserted-by":"crossref","first-page":"1779 e1","DOI":"10.1016\/j.ophtha.2006.05.015","article-title":"Results from the multicenter Boston type 1 keratoprosthesis study","volume":"113","author":"Zerbe","year":"2006","journal-title":"Ophthalmology"},{"key":"R6-20250723","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ophtha.2015.03.025","article-title":"Boston keratoprosthesis: outcomes and complications: a report by the American Academy of Ophthalmology","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"key":"R7-20250723","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jtos.2020.09.004","article-title":"Retroprosthetic membrane: a complication of keratoprosthesis with broad consequences","volume":"18","author":"Park","year":"2020","journal-title":"Ocul Surf"},{"key":"R8-20250723","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.ophtha.2014.05.030","article-title":"Long-term outcomes of boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort","volume":"121","author":"Srikumaran","year":"2014","journal-title":"Ophthalmology"},{"key":"R9-20250723","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/bjophthalmol-2019-315617","article-title":"Long-term outcomes of Boston keratoprosthesis type I: the Chinese People's Liberation Army General Hospital experience","volume":"106","author":"Wang","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R10-20250723","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ophtha.2014.08.007","article-title":"Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston type I keratoprosthesis","volume":"122","author":"Qian","year":"2015","journal-title":"Ophthalmology"},{"key":"R11-20250723","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjo.2010.193029","article-title":"Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China","volume":"96","author":"Huang","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R12-20250723","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ophtha.2009.09.024","article-title":"Short-term visual outcomes of Boston type 1 keratoprosthesis implantation","volume":"117","author":"Dunlap","year":"2010","journal-title":"Ophthalmology"},{"key":"R13-20250723","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ophtha.2012.11.025","article-title":"Retention of the Boston keratoprosthesis type 1: multicenter study results","volume":"120","author":"Ciolino","year":"2013","journal-title":"Ophthalmology"},{"key":"R14-20250723","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ICO.0b013e3181a186dc","article-title":"Boston keratoprosthesis outcomes and complications","volume":"28","author":"Chew","year":"2009","journal-title":"Cornea"},{"key":"R15-20250723","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jtos.2018.08.003","article-title":"Boston Type 2 keratoprosthesis-mid term outcomes from a tertiary eye care centre in India","volume":"17","author":"Iyer","year":"2019","journal-title":"Ocul Surf"},{"key":"R16-20250723","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/ICO.0000000000000837","article-title":"Boston keratoprosthesis type 1 in chemical burns","volume":"35","author":"Salvador-Culla","year":"2016","journal-title":"Cornea"},{"key":"R17-20250723","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ICO.0000000000000265","article-title":"Medium-term outcomes of Boston type 1 keratoprosthesis implantation in Bangkok, Thailand","volume":"33","author":"Lekhanont","year":"2014","journal-title":"Cornea"},{"key":"R18-20250723","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bjo.2009.173724","article-title":"Comparison of prognostic value of Roper Hall and Dua classification systems in acute ocular burns","volume":"95","author":"Gupta","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R19-20250723","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2017.09.005","article-title":"Treatment of acute ocular chemical burns","volume":"63","author":"Sharma","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"R20-20250723","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ophtha.2003.02.003","article-title":"Donor source affects the outcome of ocular surface reconstruction in chemical or thermal burns of the cornea","volume":"111","author":"Shimazaki","year":"2004","journal-title":"Ophthalmology"},{"key":"R21-20250723","first-page":"1601","article-title":"Long-term visual outcomes of the Boston type I keratoprosthesis in Canada","volume":"104","author":"Szigiato","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"R22-20250723","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ophtha.2005.05.022","article-title":"Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns","volume":"112","author":"Tamhane","year":"2005","journal-title":"Ophthalmology"},{"key":"R23-20250723","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ICL.0000000000000021","article-title":"Contact lens fitting and long-term management for the Boston keratoprosthesis","volume":"40","author":"Nau","year":"2014","journal-title":"Eye Contact Lens"},{"key":"R24-20250723","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/ICL.0000000000000154","article-title":"Contact lens use in patients with Boston keratoprosthesis type 1: fitting, management, and complications","volume":"41","author":"Thomas","year":"2015","journal-title":"Eye Contact Lens"},{"key":"R25-20250723","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3129\/i10-103","article-title":"Boston type 1 keratoprosthesis: the CHUM experience","volume":"46","author":"Robert","year":"2011","journal-title":"Can J Ophthalmol"},{"key":"R26-20250723","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ophtha.2012.02.015","article-title":"International results with the Boston type I keratoprosthesis","volume":"119","author":"Aldave","year":"2012","journal-title":"Ophthalmology"},{"key":"R27-20250723","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2021.06.002","article-title":"Vitreoretinal complications in Boston keratoprosthesis type 1","volume":"231","author":"Khair","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R28-20250723","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ophtha.2010.12.032","article-title":"Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis","volume":"118","author":"Greiner","year":"2011","journal-title":"Ophthalmology"},{"key":"R29-20250723","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/ICO.0b013e3182114467","article-title":"The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency","volume":"30","author":"Sejpal","year":"2011","journal-title":"Cornea"},{"key":"R30-20250723","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/ICO.0000000000002649","article-title":"Infectious keratitis after Boston type 1 keratoprosthesis implantation","volume":"40","author":"Ghaffari","year":"2021","journal-title":"Cornea"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T14:03:41Z","timestamp":1753279421000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000003563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000003563","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"2022-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}